Trial Profile
A phase I pharmacokinetic study of gastroretentive, sustained release zinc-monocysteine.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 02 Dec 2011
Price :
$35
*
At a glance
- Drugs Zinc monocysteine (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Pharmacokinetics; Therapeutic Use
- 02 Dec 2011 New trial record